Avanos (AVNS) Form 4: Insider Surrenders 345 Shares at $12.66

John Joseph Hurley, Principal Accounting Officer of Avanos Medical, Inc. (AVNS), reported a Form 4 disclosing a tax-withholding sale tied to vested restricted stock units.

Rhea-AI Filing Summary

John Joseph Hurley, Principal Accounting Officer of Avanos Medical, Inc. (AVNS), reported a Form 4 disclosing a tax-withholding sale tied to vested restricted stock units. On 09/05/2025 the filing shows 345 shares were disposed of at $12.66 per share under transaction code F(1). The filing explains these shares were surrendered to the issuer to satisfy tax withholding on time-based restricted share units awarded on 09/05/2024. After the transaction, Hurley beneficially owns 11,364 shares directly. The Form 4 was signed by an attorney-in-fact on 09/09/2025.

Positive

• Proper disclosure of the transaction on Form 4 demonstrating compliance with Section 16 reporting requirements
• Transaction tied to tax withholding on vested TRSUs, indicating a routine administrative sale rather than an opportunistic insider sale

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine insider tax-withholding sale on vested RSUs; shows compliance with disclosure and tax obligations.

The Form 4 reports a non-discretionary disposition of 345 shares to satisfy withholding on vested time-based restricted share units granted a year earlier. This is a common, non-strategic transaction that reduces the insider's net share count but does not indicate a change in company control or executive intent to liquidate holdings. The use of an attorney-in-fact for signature is procedural and acceptable when properly authorized.

Securities Analyst

TL;DR: Small, routine disposition; immaterial to company capitalization and likely unrelated to trading strategy.

Transaction details: 345 shares sold at $12.66 per share on 09/05/2025, leaving 11,364 shares beneficially owned. The sale is explicitly tied to tax withholding for TRSUs awarded 09/05/2024, indicating the transaction is administrative rather than a market-driven divestiture. Given the modest size relative to typical insider holdings, the market impact is likely negligible.

Insider Trade Summary

Exercise Price or Tax Liability: 345 shares

Exercise Price or Tax Liability 1 txn

Insider Hurley John Joseph

Role Principal Accounting Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	345	$12.66	$4K

Holdings After Transaction: Common Stock — 11,364 shares (Direct)

Footnotes (1)

1. F1. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units (TRSUs) that were awarded to the Reporting Person on September 5, 2024. Each TRSU is the economic equivalent of one share of Common Stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did AVNS insider John Joseph Hurley report on Form 4?

The Form 4 reports a disposition of 345 shares on 09/05/2025 at $12.66 per share to satisfy tax withholding on vested TRSUs.

How many Avanos (AVNS) shares does Hurley own after the transaction?

After the reported transaction Hurley beneficially owns 11,364 shares directly.

Why were the 345 shares disposed of according to the filing?

The filing states the shares were surrendered to the issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units awarded on 09/05/2024.

When was the Form 4 signed and by whom?

The Form 4 was signed by Mojirade James, attorney-in-fact for John Joseph Hurley on 09/09/2025.

Does the Form 4 indicate any derivative transactions or option exercises?

No. Table II for derivative securities contains no reported transactions; only the non-derivative sale of common stock is disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/09/2025 - 12:55 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hurley John Joseph

(Last) (First) (Middle)

5405 WINDWARD PARKWAY

SUITE 100

(Street)

ALPHARETTA GA 30004

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AVANOS MEDICAL, INC. [ AVNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Principal Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/05/2025		F(1)		345	D	$12.66	11,364	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units (TRSUs) that were awarded to the Reporting Person on September 5, 2024. Each TRSU is the economic equivalent of one share of Common Stock.

Remarks:

	/s/ Mojirade James, attorney-in-fact for John Joseph Hurley	09/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.